Learning Objectives:

1: Evaluate clinical impact of cannabinoids via the endocannabinoid system.

2: Explain current understanding of cannabinoid use and benefit in patients with GI disorders.

3: Educate patients on possible risk and side effects associated with cannabis use.


Session date: 
05/02/2023 - 4:30pm to 5:30pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Jami Kinnucan